Search research articles
Contact Us
Filters
Showing results (1-10 of 29) with videos related to
Page
of 3
Sort By:
Clinical Therapeutics
|
September 1, 1989
A double-blind clinical evaluation of the anorectic activity of phenylpropanolamine versus placebo
F Greenway
Diabetes Technology & Therapeutics
|
July 28, 2001
Obesity medications and the treatment of type 2 diabetes
F Greenway
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity
|
October 2, 2004
Evaluating commercial weight loss programmes: an evolution in outcomes research
M Hamilton, F Greenway
Beneficial Microbes
|
May 21, 2013
A novel cobiotic containing a prebiotic and an antioxidant augments the glucose control and gastrointestinal tolerability of metformin: a case report
F Greenway, S Wang, M Heiman
Journal of Doctoral Nursing Practice
|
August 21, 2020
A Case Report: The CSF Characteristics of HaNDL Syndrome
Sarah E McKay, Melanie R F Greenway
Handbook of Clinical Neurology
|
January 4, 2023
Palliative care approaches to acute stroke in the hospital setting
Melanie R F Greenway, Maisha T Robinson
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity
|
June 27, 2013
Mesotherapy for local fat reduction
S Jayasinghe, T Guillot, L Bissoon, et al.
The American Journal of Medicine
|
April 12, 2017
In Deep: Cerebral Toxoplasmosis
Melanie R F Greenway, Keith A Sacco, M Caroline Burton
Diabetes, Obesity & Metabolism
|
March 30, 2007
Topical fat reduction from the waist
M K Caruso, S Pekarovic, W J Raum, et al.
Obesity Research
|
August 10, 1999
Double-blind, randomized, placebo-controlled clinical trials with non-prescription medications for the treatment of obesity
F Greenway, D Herber, W Raum, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 29) with videos related to
Sort By:
Page
of 3
Clinical Therapeutics
|
September 1, 1989
A double-blind clinical evaluation of the anorectic activity of phenylpropanolamine versus placebo
F Greenway
Diabetes Technology & Therapeutics
|
July 28, 2001
Obesity medications and the treatment of type 2 diabetes
F Greenway
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity
|
October 2, 2004
Evaluating commercial weight loss programmes: an evolution in outcomes research
M Hamilton, F Greenway
Beneficial Microbes
|
May 21, 2013
A novel cobiotic containing a prebiotic and an antioxidant augments the glucose control and gastrointestinal tolerability of metformin: a case report
F Greenway, S Wang, M Heiman
Journal of Doctoral Nursing Practice
|
August 21, 2020
A Case Report: The CSF Characteristics of HaNDL Syndrome
Sarah E McKay, Melanie R F Greenway
Handbook of Clinical Neurology
|
January 4, 2023
Palliative care approaches to acute stroke in the hospital setting
Melanie R F Greenway, Maisha T Robinson
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity
|
June 27, 2013
Mesotherapy for local fat reduction
S Jayasinghe, T Guillot, L Bissoon, et al.
The American Journal of Medicine
|
April 12, 2017
In Deep: Cerebral Toxoplasmosis
Melanie R F Greenway, Keith A Sacco, M Caroline Burton
Diabetes, Obesity & Metabolism
|
March 30, 2007
Topical fat reduction from the waist
M K Caruso, S Pekarovic, W J Raum, et al.
Obesity Research
|
August 10, 1999
Double-blind, randomized, placebo-controlled clinical trials with non-prescription medications for the treatment of obesity
F Greenway, D Herber, W Raum, et al.
Page
of 3